Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry.
about
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and childAntiepileptic drugs during pregnancy in primary care: a UK population based studyExtraction of electronic health record data in a hospital setting: comparison of automatic and semi-automatic methods using anti-TNF therapy as model.Pregnant women with epilepsy in a developing country.Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study.Use of antiepileptic medications in pregnancy in relation to risks of birth defectsSafety aspects of antiepileptic drugs--focus on pharmacovigilance.Neurobehavioral consequences of prenatal antiepileptic drug exposure.Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions.Algorithm for lamotrigine dose adjustment before, during, and after pregnancy.Valproate prescriptions for nonepilepsy disorders in reproductive-age women.Hypertensive pregnancy complications in women with epilepsy and antiepileptic drugs: a population-based cohort study of first pregnancies in Norway.Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France
P2860
Q30249670-E50220FE-8536-4DB4-AB1C-797F517AEFDCQ34305635-1C7028A0-E43F-475C-A673-E6B1B95138BBQ34526112-03736D7D-8176-47F2-B861-365ACAA6AF41Q34572340-D821A396-0348-4D5D-A773-E97DD111D3BBQ35480124-647E91D6-B1E0-4A10-BFD5-F18491AB858EQ36347356-631A6C71-B217-45B5-85E1-8C4E6AD6D292Q36751405-22B29B14-223F-4B0C-B9E2-E91C53E884E6Q37954227-736FF329-A7E6-4A62-A483-9297BD45A409Q37980247-AF651640-85FE-4228-9C61-4ECF1DCA8DD0Q43918069-2B61D9FE-2937-4560-8F24-B1655D78CDDDQ51479292-15F6E271-78CF-4122-9087-D2162128549AQ53109252-DCE15F0F-1F4C-4B69-85AF-F35A7AF8A3A1Q55038916-E6538474-5B5C-4B3C-9A74-021060FCE91DQ57259547-2029601A-FD7B-43C9-879F-35BC7833078B
P2860
Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Utilization of antiepileptic d ...... data from the EURAP registry.
@ast
Utilization of antiepileptic d ...... data from the EURAP registry.
@en
type
label
Utilization of antiepileptic d ...... data from the EURAP registry.
@ast
Utilization of antiepileptic d ...... data from the EURAP registry.
@en
prefLabel
Utilization of antiepileptic d ...... data from the EURAP registry.
@ast
Utilization of antiepileptic d ...... data from the EURAP registry.
@en
P1433
P1476
Utilization of antiepileptic d ...... data from the EURAP registry.
@en
P2093
Eurap Study Group
P304
P356
10.1111/J.1528-1167.2009.02093.X
P577
2009-05-12T00:00:00Z